Ardent Health Partners, Inc. logo

Ardent Health Partners, Inc.(ARDT)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
2-STAR RATING
Consider higher Upturn Star rating
BUY for 24 days
PROFIT SINCE LAST BUY
+52.27% ▲
LAST CLOSE
$17.8
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for ARDT

11/13/2026: ARDT (2-star) has a low Upturn Star Rating. Not recommended to BUY.

Ardent Health Partners, Inc. is a publicly traded healthcare services company that owns and operates acute care hospitals and outpatient networks across growing mid-sized U.S. communities. The company's primary strengths include strategic academic joint ventures and disciplined cost-savings execution. Its core investment story centers on organic volume growth and network expansion, balanced against risks such as labor cost inflation, regulatory reimbursement changes, and fixed lease obligations. Ardent suits growth- and value-oriented healthcare investors willing to monitor operational execution and margin trends closely.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitArdent offers moderate revenue expansion through network scaling, though it lacks the high-growth profile typical of early-stage tech sectors.
Momentum investorStrong fit while signal remains positiveMomentum appeal depends on positive quarterly volume acceleration and favorable earnings revisions.
Value investorMixed fitThe stock trades at reasonable earnings multiples relative to healthcare peers, though lease liabilities require careful scrutiny.
Dividend investorWeak fitArdent does not pay a dividend, focusing entirely on reinvestment and debt management.
Low-risk investorWeak fitHealthcare regulatory shifts, labor cost volatility, and leverage create notable operational risk.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityMedium / highThe stock experiences fluctuations tied to quarterly earnings updates and broader healthcare sentiment.
Valuation riskMediumValuations remain sensitive to shifts in hospital sector margins and interest rate environments.
Competition risk (hospital network competition)Medium / highArdent competes against larger, well-capitalized regional and national health systems for patient volume and clinical talent.
Business qualityMediumThe company maintains solid regional market positions, though profitability is constrained by industry-wide cost pressures.
Dividend incomeLow / noneNo dividend is currently distributed to shareholders.
Execution riskMedium / highSuccess relies heavily on executing cost-savings initiatives like IMPACT and controlling labor inflation.

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.51B USD
Price to earnings Ratio 17.28
1Y Target Price 16.62
Price to earnings Ratio 17.28
1Y Target Price 16.62
Volume (30-day avg) 727.1K shares
Beta 0.58
52 Weeks Range 7.71 - 18.57
Updated Date 11/15/2026
52 Weeks Range 7.71 - 18.57
Updated Date 11/15/2026
Dividends yield (FY) -
Basic EPS (TTM) 1.03

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Care Facilities

BUY participation
88.9%
Active BUY / eligible
8 / 9
30-Day BUY Count Change
+6

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Hockey-Stick Growth
PRICE PATH

Hockey-Stick Growth

The stock demonstrates a Hockey-Stick Growth price path pattern.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type Stock
Historic Profit 11.2%
Avg. Invested days 28
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 2.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
ARDT receives a 3-star rating, supported by solid company fundamentals. The rating is constrained by limited analyst upside.

Company Fundamentals

★★★★★
ARDT has solid overall fundamentals (4 stars), with moderate financial health, moderate growth momentum, and solid ownership. In FY2025 versus FY2024, growth and ownership metrics are mixed: negative earnings growth (-35.4%), soft cash generation (FCF margin 4.1%), moderate revenue growth (+6.0%).

Financial Health Rating

★★★★★
ARDT's financial health is supported by solid cash strength, including free-cash-flow generation (4.1% of revenue). Profitability is moderate (3 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is ARDT's strongest growth driver at +102.8% FY2025 versus FY2024 (strong, 5 stars). By comparison, while revenue growth (+6.0%, moderate) and earnings growth (-35.4%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 78.1% and approximately 15.4% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 24.03% supports management-shareholder alignment.

Top 5 Institutional Investors

Chai Trust Co., LLC 54.81%
Ventas Inc 6.63%
BlackRock Inc 1.54%
Ameriprise Financial Inc 1.50%
Goldentree Asset Management LP 1.12%

Unit Economics (Per $1K Revenue)

★★★★★
ARDT generates approximately $975 of gross profit, $51 of operating income, and $41 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Moderate margins and moderate cash conversion support a 3-star rating, while capital efficiency is soft.

Economic Dimensions

★★★★★
Effective Tax Rate: 19.63%

Quantitative Style Profile

★★★★★
ARDT has a relatively low-volatility profile. No single quantitative factor dominates as a drawback.

Style Classification

Quality Focused

Momentum LeaderValue-OrientedLow VolatilitySmall / Mid Cap RiskShort Squeeze Risk

How Company Makes Money

Business areaWhat it includesRetail investor read
Inpatient Acute CareRevenues generated from overnight hospital stays, surgeries, intensive care, and specialized medical procedures.This is the core engine of the hospital business, driven by patient admissions and medical acuity.
Outpatient and Ambulatory ServicesOutpatient surgeries, physician clinic visits, diagnostic imaging, and urgent care services.Represents a growing segment as healthcare shifts away from traditional overnight hospital stays toward lower-cost settings.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2026-11-04
When After Market
Estimate 0.24
Actual 0.31

Profitability

Profit Margin 2.27%
Operating Margin (TTM) 5.08%

Management Effectiveness

Return on Assets (TTM) 3.9%
Return on Equity (TTM) 13.52%

Valuation

Trailing PE 17.28
Forward PE 14.47
Enterprise Value 4.01B
Price to Sales(TTM) 0.39
Enterprise Value 4.01B
Price to Sales(TTM) 0.39
Enterprise Value to Revenue 0.62
Enterprise Value to EBITDA 7.86
Shares Outstanding 140.94M
Shares Floating 21.65M
Shares Outstanding 140.94M
Shares Floating 21.65M
Percent Insiders 24.03
Percent Institutions 78.15

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.